Search
for
Sort by
Research 151–180 of 233
- Polycystic ovarian syndrome
- Steroid Hormones of Reproduction and Sexual Development
- Actualización del Síndrome de Ovario Poliquístico y su importancia en Dermatología
- Hormonal Treatment for Skin Androgen-Related Disorders
- Alopecia and drugs
- Les hormones sexuelles et la peau : questionnaire à l'attention des vétérinaires praticiens. Mise à jour bibliographique et synthèse
- Polycystic Ovary Syndrome in Adolescents
- Il trattamento con metformina e clomifene citrato nelle donne con sindrome dell’ovaio policistico e infertilità
- Menopause - Andropause - Anti-Aging 2008, 11.-13. Dezember 2008, Wien - Abstracts
- Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers
- The therapeutic use of androgens in women
- A Review on Nanoparticle Based Herbal Remedies for the Management of Alopecia
- Early removal of the Norplant System.
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
- Complications of Subcutaneous Contraception: A Review
- Spironolactone in hidradenitis suppurativa: a single-center
- Knowledge and beliefs about the use/abuse of oral contraceptive pills among males: A mixed-method explanatory sequential study in community pharmacy settings
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Drug‐Induced Liver Failure Following Topical Minoxidil: A Case Report
- Hormonal Contraception for the Adolescent
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
- Polycystic ovary syndrome
- 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
- Adult female acne: a guide to clinical practice
- Progestogens with Antiandrogenic Properties
- Endocrine intervention for transsexuals
- Acne
- Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology